READ POST 1 FIRST
Seeking serious contributors for this blog. Email me with academic/professional background, to get author permission. If you have written a report please send it to me at asgalib20@gmail.com.
Further analysis of the prospects of DViS in some clinical settings.
Imaging parameters the DViS will address:
A. Uses fluoroscopic technology with a rotating gantry, takes X-rays that is constructed into 3D images. So probably(since only one 3D image is available), the skeletal structures will be well defined, and the traumatologist and orthopedician may have speedy real time access to suspected fractures and dislocations. So the real value add in, is the image reconstruction technology.If DViS can produce enhanced tissue differentiation, that will be the plum in the pudding.
B. Real time imaging.
C. Ability to be transported to the patient's bed side. In case of CT or MRI, the patient has to be transferred.
Advantages in emergency traumatology:
1. Real time access- Current X-ray machines requires some time before the films can be processed and developed
2. Less radiation than X-ray or CT scan.
3. The healthcare professional may be able to take a quick decision regarding the best possible management protocol.
4. The fractures and dislocations are often fixed or operated upon by using the C-Arm. The 3D images produced by DViS may in all probability enhance procedural parameters in the hands of the trained orthopedician. Parameters that can be addressed are:
a. Safety and accessibility.
b. Speedier procedures.
c. An important point to note- Imaging itself is a means to an end, the complicated anatomy of the target region and the expertise and experience, of the doctor is also important(maybe more).
d. So if doctors are willing to get trained in procedures, that are DViS assisted, the results should be better.
So,it may be possible for DViS, at this point of time, to supercede existing modalities in the ER and traumatology settings. Let's hope for the best.
Legal disclaimer: The author may or may not have significant holdings in the company discussed.
In my opinion the most important positive price catalyst are two:
1. FDA approval, provided they have experienced doctors on their board.
2. Positive feedback from physicians, interventional radiologists and other doctors and surgeons who base their clinical practice on imaging modalities.(Sadly I found only one person claiming to be a physician, and said prospects are good. We need feedback from a healthcare professional who has seen the system in action)
Wednesday, December 30, 2009
Thursday, December 24, 2009
Stock Analysis. IMGG
Company-Imaging3 Inc.Ticker-IMGG
Product-Dominion Volumetric Imaging Scanner, the DViS.
According to the company website, DViS produces high quality, medical grade, real-time 3D images.
As claimed the main advantages are:
1. Can produce CT “like” imagery.
2. Uses dramatically less radiation.
3. Mobility –can be shifted from room to room.
4. Decreased imaging time.
5. Broad application along multiple disciplines.
6. Enhances procedural parameters.
7. Enables previously unfeasible procedures.
8. Set up is easy and costs less than a CT system.
9. Real time imaging.
All said and done, the real challenge for DViS will be to address critical imaging issues, in varied clinical settings. For the last several decades, as imaging technology, has evolved , it has become a cornerstone of medical diagnostics and therapeutic procedures. DViS can win big if it can enhance physician acceptability, albeit by demonstrating the superiority of its technology, over other imaging modalities currently in use . Not to forget , established imaging protocols, are already in place in several medical disciplines , like traumatology, interventional cardiology and cardiac surgery , general surgery and its various superspecialities, which have gained acceptance over the years as standard protocols in patient management.
A critical overview of DViS functionality vis-à-vis, in use imaging technologies, will clear part of the picture.
Strategic Hurdles for DViS.
1. Address imaging issues in varied clinical settings.
2. Increase acceptability among physicians, surgeons, and radiologists.
3. Generate sells over time.
4. FDA approval( this comes first).
The big question: Does DViS got what it takes?
Yes and No. Strategic marketing is the key.More imaging slides posted on the website will be helpful. Say, a trauma centre physician or surgeon will need images of the spleen, liver and other abdominal organs. A medical expert will need time critical information, regarding the status of the internal organs, and the site, nature and extent of the injury, to decide what kind of intervention, is most suitable for the patient.
What is required , so that the retail investor can make an informed decision?
For starters:
1. More slides taken from real patients in different clinical conditions, showing clear visualizations of internal organs, blood supply etc.
2. Detailed explanations about how Imaging3 plans to make this product more acceptable to healthcare professionals.
3. Case by case, clinical scenarios, in which DVis has outperformed other imaging modalities in addressing key imaging and clinical issues.
Watch out for the next report- Detailed analysis of probable clinical scenarios in which DViS may play a part.
Disclaimer: The author may or may not hold significant holdings in the company discussed.
Product-Dominion Volumetric Imaging Scanner, the DViS.
According to the company website, DViS produces high quality, medical grade, real-time 3D images.
As claimed the main advantages are:
1. Can produce CT “like” imagery.
2. Uses dramatically less radiation.
3. Mobility –can be shifted from room to room.
4. Decreased imaging time.
5. Broad application along multiple disciplines.
6. Enhances procedural parameters.
7. Enables previously unfeasible procedures.
8. Set up is easy and costs less than a CT system.
9. Real time imaging.
All said and done, the real challenge for DViS will be to address critical imaging issues, in varied clinical settings. For the last several decades, as imaging technology, has evolved , it has become a cornerstone of medical diagnostics and therapeutic procedures. DViS can win big if it can enhance physician acceptability, albeit by demonstrating the superiority of its technology, over other imaging modalities currently in use . Not to forget , established imaging protocols, are already in place in several medical disciplines , like traumatology, interventional cardiology and cardiac surgery , general surgery and its various superspecialities, which have gained acceptance over the years as standard protocols in patient management.
A critical overview of DViS functionality vis-à-vis, in use imaging technologies, will clear part of the picture.
Strategic Hurdles for DViS.
1. Address imaging issues in varied clinical settings.
2. Increase acceptability among physicians, surgeons, and radiologists.
3. Generate sells over time.
4. FDA approval( this comes first).
The big question: Does DViS got what it takes?
Yes and No. Strategic marketing is the key.More imaging slides posted on the website will be helpful. Say, a trauma centre physician or surgeon will need images of the spleen, liver and other abdominal organs. A medical expert will need time critical information, regarding the status of the internal organs, and the site, nature and extent of the injury, to decide what kind of intervention, is most suitable for the patient.
What is required , so that the retail investor can make an informed decision?
For starters:
1. More slides taken from real patients in different clinical conditions, showing clear visualizations of internal organs, blood supply etc.
2. Detailed explanations about how Imaging3 plans to make this product more acceptable to healthcare professionals.
3. Case by case, clinical scenarios, in which DVis has outperformed other imaging modalities in addressing key imaging and clinical issues.
Watch out for the next report- Detailed analysis of probable clinical scenarios in which DViS may play a part.
Disclaimer: The author may or may not hold significant holdings in the company discussed.
Subscribe to:
Posts (Atom)
Posts
